These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19929786)

  • 1. Overview of naphthalimide analogs as anticancer agents.
    Lv M; Xu H
    Curr Med Chem; 2009; 16(36):4797-813. PubMed ID: 19929786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel naphthalimide-benzoic acid conjugates as potential apoptosis-inducing agents: design, synthesis, and biological activity.
    Wu A; Mei P; Xu Y; Qian X
    Chem Biol Drug Des; 2011 Dec; 78(6):941-7. PubMed ID: 21958160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naphthalimides and azonafides as promising anti-cancer agents.
    Ingrassia L; Lefranc F; Kiss R; Mijatovic T
    Curr Med Chem; 2009; 16(10):1192-213. PubMed ID: 19355879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Non-amino aromatic substituted naphthalimides as potential antitumor agents: Synthesis via Suzuki reaction, antiproliferative activity, and DNA-binding behavior.
    Xie L; Cui J; Qian X; Xu Y; Liu J; Xu R
    Bioorg Med Chem; 2011 Jan; 19(2):961-7. PubMed ID: 21208805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, in vitro evaluation and molecular modelling of naphthalimide analogue as anticancer agents.
    Verma M; Luxami V; Paul K
    Eur J Med Chem; 2013 Oct; 68():352-60. PubMed ID: 23994328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BND-12, a novel nonhaematotoxic naphthalimide derivative, inhibits tumour growth and metastasis of hepatocellular carcinoma.
    Xie SQ; Li Q; Zhang YH; Li Z; Zhao J; Wang CJ
    J Pharm Pharmacol; 2012 Oct; 64(10):1483-90. PubMed ID: 22943179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,8-Naphthalimide: A Potent DNA Intercalator and Target for Cancer Therapy.
    Tandon R; Luxami V; Kaur H; Tandon N; Paul K
    Chem Rec; 2017 Oct; 17(10):956-993. PubMed ID: 28375569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin- 5-yl}carbamoyl)acetamide (UNBS3157), a novel nonhematotoxic naphthalimide derivative with potent antitumor activity.
    Van Quaquebeke E; Mahieu T; Dumont P; Dewelle J; Ribaucour F; Simon G; Sauvage S; Gaussin JF; Tuti J; El Yazidi M; Van Vynckt F; Mijatovic T; Lefranc F; Darro F; Kiss R
    J Med Chem; 2007 Aug; 50(17):4122-34. PubMed ID: 17658777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naphthalimide derivatives with therapeutic characteristics: a patent review.
    Kamal A; Bolla NR; Srikanth PS; Srivastava AK
    Expert Opin Ther Pat; 2013 Mar; 23(3):299-317. PubMed ID: 23369185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis, and Evaluation of Novel 3-Carboranyl-1,8-Naphthalimide Derivatives as Potential Anticancer Agents.
    Rykowski S; Gurda-Woźna D; Orlicka-Płocka M; Fedoruk-Wyszomirska A; Giel-Pietraszuk M; Wyszko E; Kowalczyk A; Stączek P; Bak A; Kiliszek A; Rypniewski W; Olejniczak AB
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxo-heterocyclic fused naphthalimides as antitumor agents: synthesis and biological evaluation.
    Tan S; Yin H; Chen Z; Qian X; Xu Y
    Eur J Med Chem; 2013 Apr; 62():130-8. PubMed ID: 23353750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, electrochemistry, DNA binding and in vitro cytotoxic activity of tripodal ferrocenyl bis-naphthalimide derivatives.
    Fan YR; Wang BJ; Jia DG; Yang XB; Huang Y
    J Inorg Biochem; 2021 Jun; 219():111425. PubMed ID: 33831713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Outlook of the Structure Activity Relationship (SAR) of Naphthalimide Derivatives as Anticancer Agents.
    Bhat AA
    Anticancer Agents Med Chem; 2024; 24(2):96-116. PubMed ID: 37974443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthesis and in vitro cytotoxicity of naphthalimide polyamine conjugates as antitumor agents].
    Mei ZH; Tian ZY; Ma HX; Xie SQ; Zhao J; Wang CJ
    Yao Xue Xue Bao; 2009 Jul; 44(7):754-7. PubMed ID: 19806915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remarkable DNA binding affinity and potential anticancer activity of pyrrolo[2,1-c][1,4]benzodiazepine-naphthalimide conjugates linked through piperazine side-armed alkane spacers.
    Kamal A; Ramu R; Tekumalla V; Khanna GB; Barkume MS; Juvekar AS; Zingde SM
    Bioorg Med Chem; 2008 Aug; 16(15):7218-24. PubMed ID: 18656370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments on 1,8-Naphthalimide moiety as potential target for anticancer agents.
    Tandon R; Luxami V; Tandon N; Paul K
    Bioorg Chem; 2022 Apr; 121():105677. PubMed ID: 35202852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of naphthalimide-carborane and metallacarborane conjugates: Anticancer activity, DNA binding ability.
    Nekvinda J; Różycka D; Rykowski S; Wyszko E; Fedoruk-Wyszomirska A; Gurda D; Orlicka-Płocka M; Giel-Pietraszuk M; Kiliszek A; Rypniewski W; Bachorz R; Wojcieszak J; Grüner B; Olejniczak AB
    Bioorg Chem; 2020 Jan; 94():103432. PubMed ID: 31776032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and study of antiproliferative, antitopoisomerase II, DNA-intercalating and DNA-damaging activities of arylnaphthalimides.
    Quintana-Espinoza P; García-Luis J; Amesty A; Martín-Rodríguez P; Lorenzo-Castrillejo I; Ravelo AG; Fernández-Pérez L; Machín F; Estévez-Braun A
    Bioorg Med Chem; 2013 Nov; 21(21):6484-95. PubMed ID: 24054489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel naphthalimide-amino acid conjugates with flexible leucine moiety as side chain: design, synthesis and potential antitumor activity.
    Wu A; Xu Y; Qian X
    Bioorg Med Chem; 2009 Jan; 17(2):592-9. PubMed ID: 19109022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, DNA Binding, and Anticancer Properties of Bis-Naphthalimide Derivatives with Lysine-Modified Polyamine Linkers.
    Huang Y; Wu CX; Song Y; Huang M; Tian DN; Yang XB; Fan YR
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29382135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.